Besides, univariate and multivariate analysis confirmed that PDLIM2 expression was independently associated with longer OS in ESCC patients (HR: 0.64, 95% CI: 0.43‐0.95, P = 0.03), after adjustment for gender and pathologic stages. The gene discussed is PDLIM2; the disease is esophageal squamous cell carcinoma.